KCNJ12 and Prader-Willi syndrome: Therefore, it is possible that KCNJ12 mutation caused PWS pathology by activating the AKT pathway, targeting KCNJ12 or the AKT signaling pathway might be a candidate intervention in the treatment of this disease.